Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.
Clinical trial NCT06273943 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06273943
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-10-30
- Enrollment
- 322
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.